Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community- acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home

Annals of Pharmacotherapy

Volumn 47, Issue 1, 2013, Pages 9-19

  Chen, Jenny I ^a,b   Slater, Leonard N ^a,c   Kurdgelashvili, George ^a,c   Husain, Khawaja O ^d,e   Gentry, Chris A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e Platte Valley Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; GATIFLOXACIN; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; EMERGENCY CARE; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME; WARD;

AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872979661     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R322     Document Type: Article

References (39)

1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventila- tor-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416. doi: 10.1164/rccm.200405-644ST
2. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epi- demiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854-62. doi: 10.1378/chest.128.6.3854
3. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH. Antimicro- bial therapy escalation and hospital mortality among patients with health- care-associated pneumonia: a single-center experience. Chest 2008;134: 963-8. doi: 10.1378/chest.08-0842
4. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009;135:633-640. doi: 10.1378/chest.08-1357
5. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care- associated pneumonia. Arch Intern Med 2008;168:2205-2210.
6. El-Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumo- nia in the very elderly. Am J Respir Crit Care Med 2001;163:645-651.
7. El-Solh AA, Aquilina AT, Dhillon RS, Ramadan F, Nowak P, Davies J. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med 2002;166:1038- 1043. doi: 10.1164/rccm.200202-123OC
8. El Solh AA, Pietrantoni C, Bhat A, Bhora M, Berbary E. Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin Infect Dis 2004;39:474-480.
9. Pop-Vicas AE, D'Agata EM. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clin Infect Dis 2005; 40:1792-1798.
10. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health care-associat- ed pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007;167:1393-1399.
11. Park HK, Song JU, Um SW, et al. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med 2010;104:1729-35. doi: 10.1016/j.rmed.2010.06.009
12. Grenier C, Pépin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-ac- quired pneumonia. J Antimicrob Chemother 2011;66:1617-24. doi: 10.1093/jac/dkr176
13. Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011;38: 878-887.
14. Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiot- ic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011;53:107-113. doi: 10.1093/cid/cir274
15. Garcia-Vidal C, Viasus D, Roset A, et al. Low incidence of multidrug-re- sistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 2011;17:1659-1665. doi: 10.1111/j.1469-0691.2011.03484.x
16. Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, man- agement, and outcomes-proceedings of the HCAP summit. Clin Infect Dis 2008;46:S296-S334. doi: 10.1086/526355
17. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of com- munity-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010;10:279-287.
18. Yu VL. Guidelines for hospital-acquired pneumonia and health-care-as- sociated pneumonia: a vulnerability, a pitfall, and a fatal flaw. Lancet In- fect Dis 2011;11:248-252.
19. Fujitani S, Yu VL. A new category-healthcare-associated pneumonia: a good idea, but problems with its execution. Eur J Clin Microbiol Infect Dis 2006;25:627-631. doi: 10.1007/s10096-006-0197-9
20. Brito V, Niederman MS. Healthcare-associated pneumonia is a heteroge- neous disease, and all patients do not need the same broad-spectrum an- tibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 2009;22:316-325. doi: 10.1097/QCO.0b013e328329fa4e
21. Attridge RT, Frei CR. Health care-associated pneumonia: an evidence- based review. Am J Med 2011;124:689-697. doi: 10.1016/j.amjmed.2011.01.023
22. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identi- fication of novel risk factors. Clin Infect Dis 2007;45:1543-1549. doi: 10.1086/523582
23. Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA. Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 2002;46:854-858. doi: 10.1128/AAC.46.3.854-858.2002
24. Oztoprak N, Cevik MA, Akinci E, et al. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections. Am J Infect Con- trol 2006;34:1-5. doi: 10.1016/j.ajic.2005.07.005
25. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN. Guideline-con- cordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 2009;169:1525-1531.
26. Arnold FW, LaJoie AS, Brock GN, et al.; Community-Acquired Pneu- monia Organization (CAPO) Investigators. Improving outcomes in el- derly patients with community-acquired pneumonia by adhering to na- tional guidelines: Community-Acquired Pneumonia Organization Inter- national cohort study results. Arch Intern Med 2009;169:1515-1524.
27. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Soci- ety of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27-S72. doi: 10.1086/511159
28. Niederman MS, Mandell LA, Anzueto A, et al.; American Thoracic So- ciety. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-1754.
29. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low- risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250.
30. Park SC, Kang YA, Park BH, et al. Poor prediction of potentially drug- resistant pathogens using current criteria of health care-associated pneu- monia. Respir Med 2012;106:1311-1319.
31. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in nonnosoco- mial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest 2010;137:1283-1288. doi: 10.1378/chest.09-2434
32. Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL. Predicting antibi- otic resistance to community-acquired pneumonia antibiotics in culture- positive patients with healthcare-associated pneumonia. J Hosp Med 2012;7:195-202. doi: 10.1002/jhm.942
33. Labelle AJ, Arnold H, Reichley RM, Micek ST, Kollef MH. A compari- son of culture-positive and culture-negative health-care-associated pneu- monia. Chest 2010;137:1130-7. doi: 10.1378/chest.09-1652
34. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a sin- gle-center experience. Antimicrob Agents Chemother 2007;51:3568-73. doi: 10.1128/AAC.00851-07
35. Kett DH, Cano E, Quartin AA, et al. Improving Medicine through Path- way Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators. Implementation of guidelines for man- agement of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011;11:181-189. doi: 10.1016/S1473-3099(10)70314-5
36. Madaras-Kelly KJ, Remington RE, Sloan KL, Fan VS. Guideline-based antibiotics and mortality in healthcare-associated pneumonia. J Gen In- tern Med 2012;27:845-852. doi: 10.1007/s11606-012-2011-y
37. Kovaleva A, Remmelts HH, Rijkers GT, Hoepelman AI, Biesma DH, Oosterheert JJ. Immunomodulatory effects of macrolides during commu- nity-acquired pneumonia: a literature review. J Antimicrob Chemother 2012;67:530-540. doi: 10.1093/jac/dkr520
38. Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010;23:590-615. doi: 10.1128/CMR.00078-09
39. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995;333:1618-1624.